The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece

Clinical Microbiology and Infection

Volumn 5, Issue 12, 1999, Pages 763-765

  Papaparaskevas, J ^a,b   Stefanou, J ^b   Vatopoulos, A ^c   Thomopoulos, G ^b   Avlami, A ^b  

^a GR 151 21 ^*  (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCONAZOLE; IMIPENEM; MEROPENEM; OFLOXACIN; ORNIDAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULBACTAM; SULFAMETHOXAZOLE; TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CASE REPORT; ENTEROCOCCUS FAECIUM; GREECE; HUMAN; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; TEACHING HOSPITAL;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0033381095     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00711.x     Document Type: Article

References (16)

1. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
2. Chenoweth C, Shaberg D. The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis 1990; 9: 80-9.
3. Murray BE. What can we do about vancomycin-resistant enterococci? Clin Infect Dis 1995; 20: 1134-6.
4. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994; 34: 515-28.
5. Van der Auwera P, Pensart N, Korten V, Murray B, Leclercq R. Influence of oral glycopeptide on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129-36.
6. Dutka-Mallen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33(1): 24-7.
7. Murray BE. Diversity among multidrug-resistant enterococci. Emerg Infect Dis 1998; 4(1): 37-47.
8. Leqlerc R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-61.
9. Swenson JM, Clark NM, Ferraro MJ, et al. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 1997; 32(7): 1700-4.
10. Giamarellou H, Xirouchaki E, the Amfiaraeion Center for Chemotherapeutic Studies. Epidemiology of nosocomial Enterococcus spp. isolates from hospitals in Athens [abstract 155]. In: Program and abstracts of the 23rd Panhellenic Medical Conference, Athens, Greece. Athens: Athens Medical Society. 1997: 41.
11. WHONET Greece. Susceptibility results of Gram-positive cocci for the period Jan-Dec 1997. Arch Hellenic Med 1998; 15(2): 221-2.
12. Douboyas J, Tsakris A. Prevalence of antibiotic resistance among enterococci isolated in Greece. J Antimicrob Chemother 1995; 35: 236-8.
13. Tsakris A, Pournaras S, Douboyas J. Changes in antimicrobial resistance of enterococci isolated in Greece. J Antimicrob Chemother 1997; 40: 735-7.
14. Papaparaskevas J, Stefanou J, Tzivra M, Zoga P, Matsas M, Avlami A. Using the WHONET software to monitor antibiotic resistance in a large teaching hospital; results for the years 1994-1995. Acta Microbiol Hell 1996; 41(4): 357-67.
15. Barton AL, Doern GV. Selective media for detecting gastrointestinal carriage of vancomycin-resistant enterococci. Diagn Microbiol Infect Dis 1995; 23: 119-22.
16. Chatzipanagiotou S, Vatopoulos A, Tassios P, Perogamvros A, Legakis N. Gastrointestinal carriage with vancomycin-resistant enterococci. In Program and abstracts of the 18th National Conference of Clinical Microbiology, Athens, Greece. Athens: Hellenic Society for Microbiology, 1998: 79.